Clinical trial · Interventional
Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
A Randomised Controlled Pilot Trial of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
NCT03581188CI-TRIAL-00068386MEL-SELFcompletedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this pilot study is to evaluate digitally supported skin self-examination compared to usual care in people treated for localised melanoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma (Skin) | Melanoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Clinician-led surveillance | Behavioral | — | UNRESOLVED |
| Patient-led surveillance | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Patient-led surveillance
- description
- Participants receive a mobile dermatoscope that attaches to their smartphone to take photos of skin lesions for teledermatology, instructions on skin self-examination from the ASICA skin checker App, text and email reminders to perform self-examination every 2 months, an educational booklet 'Your guide to early melanoma', and scheduled visits to their clinician as required.
- interventionNames
- Device: Patient-led surveillance
- type
- ACTIVE_COMPARATOR
- label
- Clinician-led surveillance
- description
- Participants receive an educational booklet 'Your guide to early melanoma' and scheduled visits to their clinician as required.
- interventionNames
- Behavioral: Clinician-led surveillance
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients treated for stage 0/I/II melanoma and are attending regular melanoma follow-up as indicated by scheduled visit within next 12 months in clinic patient booking system and * Are able to self-examine; * Have a suitable study partner (spouse, partner, family member, friend); * Have a smart phone with access to Wifi / email / SMS text messaging; * Are able to give informed consent ; * Have sufficient English language skills to read the materials and complete the questionnaires; Exclusion Criteria: * Unable to perform self-examination * No partner or friend to help with self-examination * Do not have access to a smart phone with Wifi/email/SMS text messaging * With a known past or current diagnosis of cognitive impairment
References
Publications (1)
- DERIVEDDrabarek D, Ackermann D, Medcalf E, Bell KJL. Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial. JMIR Dermatol. 2023 Jun 26;6:e45865. doi: 10.2196/45865. PMID 37632976